GPX4 and cancer: Sensitivity profiling of 177 cancer cell lines to 12 ferroptosis-inducing small molecules (including erastin, RSL3, and their analogs) revealed that diffuse large B-cell lymphomas and renal cell carcinomas are particularly susceptible to ferroptosis through GPX4 inhibition [26].